CBT
RARE icon

Capital Bank & Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History

Capital Bank & Trust’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-60,332
Closed -$5.75M – 150
2021
Q2 		$5.75M Buy
60,332
+10
+0% +$1.04K 0.07% 145
2021
Q1 		$6.87M Sell
60,322
-315
-0.5% -$42.9K 0.08% 147
2020
Q4 		$8.39M Sell
60,637
-850
-1% -$101K 0.1% 132
2020
Q3 		$5.05M Buy
61,487
+432
+0.7% +$35.8K 0.07% 136
2020
Q2 		$4.78M Buy
61,055
+2,351
+4% +$156K 0.07% 138
2020
Q1 		$2.61M Buy
58,704
+96
+0.2% +$4.99K 0.04% 158
2019
Q4 		$2.5M Sell
58,608
-70,092
-54% -$2.89M 0.03% 159
2019
Q3 		$5.51M Sell
128,700
-34,892
-21% -$1.9M 0.08% 135
2019
Q2 		$10.3M Buy
163,592
+5,326
+3% +$339K 0.13% 117
2019
Q1 		$10.9M Buy
158,266
+37,959
+32% +$2.17M 0.14% 115
2018
Q4 		$5.23M Buy
120,307
+1,348
+1% +$73.7K 0.08% 134
2018
Q3 		$9.08M Sell
118,959
-1,186
-1% -$96.5K 0.11% 120
2018
Q2 		$9.24M Buy
120,145
+720
+0.6% +$46.5K 0.12% 122
2018
Q1 		$6.09M Buy
119,425
+15,284
+15% +$770K 0.08% 134
2017
Q4 		$4.83M Sell
104,141
-17,273
-14% -$847K 0.07% 138
2017
Q3 		$6.47M Sell
121,414
-547
-0.4% -$32.4K 0.08% 137
2017
Q2 		$7.58M Buy
+121,961
New +$7.35M 0.1% 131

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Capital Bank & Trust's RARE Position: Q3 2021 in Review

Capital Bank & Trust sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2021, closing a stake of 60,332 shares — an estimated $5.75M sold.

Capital Bank & Trust first reported a position in RARE in Q2 2017 and held it in 17 quarters. The position peaked at $10.9M in Q1 2019. 222 funds tracked by Wall St. Rank hold RARE as of Q3 2021.

  • Capital Bank & Trust reported no remaining Ultragenyx Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 60,332 Ultragenyx Pharmaceutical shares in Q3 2021, an estimated $5.75M.
  • Capital Bank & Trust first reported a position in Ultragenyx Pharmaceutical in Q2 2017 and held it in 17 quarters.
  • Capital Bank & Trust's Ultragenyx Pharmaceutical position peaked at $10.9M in Q1 2019.
  • 222 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2021.

Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.